Martin James Joseph
SEC insider (Form 3/4/5 filer). CIK 0001510224. Co-CEO and CFO at Cocrystal Pharma, Inc. (COCP). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in MIAMI, FL.
Companies Martin James Joseph has filed insider reports for
- Cocrystal Pharma, Inc. (COCP): Officer, Co-CEO and CFO
Martin James Joseph
CIK: 0001510224
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COCP
Cocrystal Pharma, Inc.
Officer